Eledon Pharmaceuticals, Inc.
ELDNNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $261.35M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.35$4.60
- Volume (live)
- -
- Avg. volume (3M)
- 800.05K
Eledon Pharmaceuticals (ELDN) Stock Price & Financial Analysis
Eledon Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.20 - $2.35 |
|---|---|
| 52-Week High | $4.60 |
| 52-Week Low | $1.35 |
| Open | $2.29 |
| Volume (last close) | 420.02K |
| Average Volume (3M) | 800.05K |
| 50-Day MA | $2.86 |
|---|---|
| 200-Day MA | $3.08 |
| 1-Year Change | −30.09% |
| Market Cap | 261.35M |
|---|---|
| Shares Outstanding | 113.63M |
| Price to Book (P/B) | 3.63 |
| EV/EBITDA | -2.49 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Eledon Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Eledon Pharmaceuticals (ELDN) has a market capitalization of $261.35M.
As of its latest reported balance sheet, it holds $6.80M in cash and securities against $467.00K of debt, a net cash position of $6.34M.
Eledon Pharmaceuticals does not currently pay a dividend.
The share price is down 30.1% over the past year. At $2.30 (the Oct 23, 2026 close) it sits within its 52-week range of $1.35 to $4.60, below its 200-day moving average of $3.08.
Frequently Asked Questions About Eledon Pharmaceuticals
What is the current stock price for ELDN?
As of the Oct 23, 2026 close, ELDN stock trades at $2.30. The 52-week range is $1.35–$4.60, with a day range of $2.19–$2.35.
What is the P/E ratio for ELDN?
The P/E ratio (Price-to-Earnings) for ELDN is shown in the Key Statistics section. This valuation metric helps compare Eledon Pharmaceuticals, Inc. to industry peers.
Does ELDN pay dividends?
Eledon Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ELDN?
Analyst ratings and recommendations for ELDN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ELDN?
As of the Oct 23, 2026 close, Eledon Pharmaceuticals's market capitalization is $261.4M, classifying it as a micro-cap company. Eledon Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.